MENU
Updates from LinkedIn follow-us

Blog

  • You are here
  • Home
  • Entrepreneurship
  • Cyteir Secures $80 Million Series C Financing to Advance Novel Cancer Therapy Program
Cyteir Secures $80 Million Series C Financing to Advance Novel Cancer Therapy Program
  • 12
  • 02
  • 2021

Cyteir Secures $80 Million Series C Financing to Advance Novel Cancer Therapy Program

by David E Shaw

As a co-founder of Cyteir Therapeutics, and chair emeritus of The Jackson Laboratory where this technology originated with Dr. Kevin Mills, I share news of Cyteir’s $80mm Series C financing. And I send congratulations to the Cyteir team for their remarkable accomplishments!

Read Cyteir’s press release